432.49
price down icon0.35%   -1.54
 
loading

Amgen Inc Azioni (AMGN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
16.66%
10,054.00
8,618.00 9,866.00 9,557.00 9,179.00
Cost Of Revenue
2.44%
2,811.00
2,744.00 2,976.00 3,082.00 3,011.00
Selling, General, and Administrative
8.93%
1,745.00
1,602.00 - - -
Costs And Expenses
9.88%
6,540.00
5,952.00 7,146.00 7,031.00 6,523.00
Depreciation and Amortization
0.91%
222.00
220.00 226.00 232.00 220.00
Operating Income/Loss
31.81%
3,514.00
2,666.00 2,720.00 2,526.00 2,656.00
Nonoperating Income/Loss
197.33%
-73.00
75.00 -553.00 2,080.00 -394.00
Income/Loss From Continuing Operations Before Tax
32.82%
2,768.00
2,084.00 1,514.00 3,921.00 1,568.00
Income Tax Expense/Benefit
48.30%
393.00
265.00 181.00 705.00 136.00
Net Income/Loss
30.57%
2,375.00
1,819.00 1,333.00 3,216.00 1,432.00
Basic Average Shares
0.00%
540.00
540.00 - 538.00 538.00
Diluted Average Shares
0.00%
544.00
544.00 - 542.00 541.00
Basic Earnings Per Share
30.56%
4.40
3.37 2.47 5.98 2.66
Diluted Earnings Per Share
30.84%
4.37
3.34 2.46 5.93 2.65
Common Stock Dividends
100.00%
-
2.52 2.38 2.38 -
AZN AZN
$165.41
price down icon 0.76%
$156.19
price down icon 0.75%
NVS NVS
$150.62
price up icon 0.16%
NVO NVO
$38.83
price down icon 0.99%
PFE PFE
$29.58
price up icon 0.48%
BMY BMY
$59.75
price down icon 1.35%
Capitalizzazione:     |  Volume (24 ore):